Načítá se...
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
BACKGROUND: Breast cancer (BC) is the leading cause of cancer death for Chilean women. About 11% of cases are triple-negative (TN) BC. These are characterised by poor prognosis, higher risk of early recurrence and visceral dissemination versus other BC subtypes. Current standard treatment for early-...
Uloženo v:
Vydáno v: | Ecancermedicalscience |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Cancer Intelligence
2021
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987491/ https://ncbi.nlm.nih.gov/pubmed/33777171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1178 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|